Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions

収録刊行物

被引用文献 (14)*注記

もっと見る

キーワード

問題の指摘

ページトップへ